Literature DB >> 23806867

Is aristolochic acid nephropathy a widespread problem in developing countries? A case study of Aristolochia indica L. in Bangladesh using an ethnobotanical-phytochemical approach.

Johanna Michl1, Hannah M Jennings, Geoffrey C Kite, Martin J Ingrouille, Monique S J Simmonds, Michael Heinrich.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Species of Aristolochia are associated with aristolochic acid nephropathy (AAN), a renal interstitial fibrosis and upper urinary tract cancer (UUC). Aristolochic acid nephropathy has been reported in ten countries but its true incidence is unknown and most likely underestimated. By combining an ethnobotanical and phytochemical approach we provide evidence for the risk of AAN occurring in Bangladesh. More specifically, we assess the intra-specific variation of aristolochic acid analogues in medicinally used Aristolochia indica samples from Bangladesh.
MATERIALS AND METHODS: Ethnobotanical information was collected from 16 kavirajes (traditional healers) in different study locations in Bangladesh. Plant samples were obtained from native habitats, botanical gardens, herbal markets and pharmaceutical companies. The samples were extracted using 70% methanol and were analysed using LC-DAD-MS and (1)H-NMR.
RESULTS: Roots as well as leaves are commonly used for symptoms such as snake bites and sexual problems. Among the informants knowledge about toxicity or side effects is very limited and Aristolochia indica is often administered in very high doses. Replacement of Aristolochia indica with other medicinal plants such as Rauvolfia serpentina (L.) Benth. ex Kurz was common. Aristolochia indica samples contained a variety of aristolochic acid analogues such as aristolochic acid I, aristolochic acid II, cepharadione A and related compounds.
CONCLUSIONS: AAN cases are likely to occur in Bangladesh and more awareness needs to be raised about the health risks associated with the use of Aristolochia indica and other species of Aristolochia as herbal medicines.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  3-(tetramethylsilyl)propionic-2,2,3,3-d4 acid, sodium salt; A; AA; AAA; AAN; AL; Aristolochia indica; Aristolochic acid; BA; BEN; Balkan endemic nephropathy; Bangladesh; COSY; CP; D(2)O; EBC; ESI; GNP; HMBC; HMQC; J-RES; J-resolved; K(2)HPO(4); KH(2)PO(4); Kidney; LC-DAD-MS; LC-MS; MS; MeOD; Metabolomics; NMR; NOESY; PC; PCA; PPM; PTFE; RBG; RPM; Royal Botanic Gardens, Kew; S; TSP; Toxicity; UUC; UV; alstonine; aristolactam; aristolochic acid; aristolochic acid analogue; aristolochic acid nephropathy; benzoic acid; commercial product; correlation spectroscopy; deuterated methanol; deuterated water; di-potassium hydrogen orthophosphate; economic botany collection; electrospray ionisation; gross national product; heteronuclear multiple-bond correlation spectroscopy; heteronuclear multiple-quantum correlation spectroscopy; liquid chromatography-diode array detector-mass spectrometry; liquid chromatography-mass spectrometry; m/z; market sample; mass-to-charge-ratio; nuclear Overhauser effect spectroscopy; nuclear magnetic resonance; parts per million; polyfluoroethylene; potassium dihydrogen orthophosphate; principle component; principle component analysis; retention time; revolutions per minute; serpentine; t(R); ultraviolet; upper urinary tract cancer

Mesh:

Substances:

Year:  2013        PMID: 23806867     DOI: 10.1016/j.jep.2013.06.028

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  14 in total

1.  Balkan endemic nephropathy and aristolochic acid I: an investigation into the role of soil and soil organic matter contamination, as a potential natural exposure pathway.

Authors:  Alexandra T Gruia; Camelia Oprean; Alexandra Ivan; Ada Cean; Mirabela Cristea; Lavinia Draghia; Roxana Damiescu; Nikola M Pavlovic; Virgil Paunescu; Calin A Tatu
Journal:  Environ Geochem Health       Date:  2017-12-29       Impact factor: 4.609

Review 2.  Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatment.

Authors:  Randy L Luciano; Mark A Perazella
Journal:  Drug Saf       Date:  2015-01       Impact factor: 5.606

3.  Quantification of adulteration in traded ayurvedic raw drugs employing machine learning approaches with DNA barcode database.

Authors:  Suma Arun Dev; Remya Unnikrishnan; R Jayaraj; P Sujanapal; V Anitha
Journal:  3 Biotech       Date:  2021-10-18       Impact factor: 2.406

Review 4.  Aristolochic acid-associated cancers: a public health risk in need of global action.

Authors:  Samrat Das; Shefali Thakur; Michael Korenjak; Viktoriya S Sidorenko; Felicia Fei-Lei Chung; Jiri Zavadil
Journal:  Nat Rev Cancer       Date:  2022-07-19       Impact factor: 69.800

5.  The efficacy of machine learning algorithm for raw drug authentication in Coscinium fenestratum (Gaertn.) Colebr. employing a DNA barcode database.

Authors:  Remya Unnikrishnan; M Sumod; R Jayaraj; P Sujanapal; Suma Arun Dev
Journal:  Physiol Mol Biol Plants       Date:  2021-03-15

6.  An integrated system for identifying the hidden assassins in traditional medicines containing aristolochic acids.

Authors:  Lan Wu; Wei Sun; Bo Wang; Haiyu Zhao; Yaoli Li; Shaoqing Cai; Li Xiang; Yingjie Zhu; Hui Yao; Jingyuan Song; Yung-Chi Cheng; Shilin Chen
Journal:  Sci Rep       Date:  2015-08-13       Impact factor: 4.379

7.  Mutation signatures implicate aristolochic acid in bladder cancer development.

Authors:  Song Ling Poon; Mi Ni Huang; Yang Choo; John R McPherson; Willie Yu; Hong Lee Heng; Anna Gan; Swe Swe Myint; Ee Yan Siew; Lian Dee Ler; Lay Guat Ng; Wen-Hui Weng; Cheng-Keng Chuang; John Sp Yuen; See-Tong Pang; Patrick Tan; Bin Tean Teh; Steven G Rozen
Journal:  Genome Med       Date:  2015-04-28       Impact factor: 11.117

8.  Differential microRNA expression in aristolochic acid-induced upper urothelial tract cancers ex vivo.

Authors:  Le Tao; Yigang Zeng; Jun Wang; Zhihong Liu; Bing Shen; Jifu Ge; Yong Liu; Yifeng Guo; Jianxin Qiu
Journal:  Mol Med Rep       Date:  2015-09-15       Impact factor: 2.952

Review 9.  An Integrated View of Aristolochic Acid Nephropathy: Update of the Literature.

Authors:  Inès Jadot; Anne-Emilie Declèves; Joëlle Nortier; Nathalie Caron
Journal:  Int J Mol Sci       Date:  2017-01-29       Impact factor: 5.923

10.  Aristolochic acid IVa forms DNA adducts in vitro but is non-genotoxic in vivo.

Authors:  Jingjing Wan; Ruixue Chen; Zhou Yang; Jing Xi; Yiyi Cao; Yu Chen; Xinyu Zhang; Yang Luan
Journal:  Arch Toxicol       Date:  2021-07-05       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.